Advertisement
Singapore markets closed
  • Straits Times Index

    3,410.81
    -29.07 (-0.85%)
     
  • Nikkei

    40,912.37
    -1.28 (-0.00%)
     
  • Hang Seng

    17,799.61
    -228.67 (-1.27%)
     
  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     
  • Bitcoin USD

    57,062.88
    +1,328.98 (+2.38%)
     
  • CMC Crypto 200

    1,184.00
    -24.69 (-2.04%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • Dow

    39,375.87
    +67.87 (+0.17%)
     
  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     
  • Gold

    2,399.80
    +30.40 (+1.28%)
     
  • Crude Oil

    83.44
    -0.44 (-0.52%)
     
  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     
  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     
  • Jakarta Composite Index

    7,253.37
    +32.48 (+0.45%)
     
  • PSE Index

    6,492.75
    -14.74 (-0.23%)
     

Are Investors Undervaluing Nova Cannabis Inc. (TSE:NOVC) By 50%?

Key Insights

  • Using the 2 Stage Free Cash Flow to Equity, Nova Cannabis fair value estimate is CA$1.81

  • Current share price of CA$0.91 suggests Nova Cannabis is potentially 50% undervalued

  • Industry average discount to fair value of 43% suggests Nova Cannabis' peers are currently trading at a lower discount

In this article we are going to estimate the intrinsic value of Nova Cannabis Inc. (TSE:NOVC) by estimating the company's future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Don't get put off by the jargon, the math behind it is actually quite straightforward.

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

ADVERTISEMENT

See our latest analysis for Nova Cannabis

The Method

We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) forecast

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

Levered FCF (CA$, Millions)

CA$11.1m

CA$10.0m

CA$9.36m

CA$8.99m

CA$8.80m

CA$8.72m

CA$8.71m

CA$8.76m

CA$8.84m

CA$8.95m

Growth Rate Estimate Source

Analyst x2

Analyst x2

Est @ -6.42%

Est @ -3.91%

Est @ -2.16%

Est @ -0.93%

Est @ -0.07%

Est @ 0.53%

Est @ 0.95%

Est @ 1.24%

Present Value (CA$, Millions) Discounted @ 9.8%

CA$10.2

CA$8.3

CA$7.1

CA$6.2

CA$5.5

CA$5.0

CA$4.5

CA$4.1

CA$3.8

CA$3.5

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CA$58m

After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (1.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 9.8%.

Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = CA$8.9m× (1 + 1.9%) ÷ (9.8%– 1.9%) = CA$116m

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CA$116m÷ ( 1 + 9.8%)10= CA$45m

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is CA$103m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of CA$0.9, the company appears quite good value at a 50% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

dcf
dcf

Important Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Nova Cannabis as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 9.8%, which is based on a levered beta of 1.579. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Nova Cannabis

Strength

  • Debt is well covered by cash flow.

Weakness

  • Interest payments on debt are not well covered.

Opportunity

  • Has sufficient cash runway for more than 3 years based on current free cash flows.

  • Trading below our estimate of fair value by more than 20%.

Threat

  • No apparent threats visible for NOVC.

Looking Ahead:

Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. What is the reason for the share price sitting below the intrinsic value? For Nova Cannabis, we've compiled three additional elements you should look at:

  1. Risks: You should be aware of the 3 warning signs for Nova Cannabis (1 can't be ignored!) we've uncovered before considering an investment in the company.

  2. Future Earnings: How does NOVC's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

PS. Simply Wall St updates its DCF calculation for every Canadian stock every day, so if you want to find the intrinsic value of any other stock just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.